FMP

FMP

blog post title

BofA Maintains Buy Rating on NVIDIA After Groq Licensing News

BofA Securities reiterated its Buy rating and $275 price target on NVIDIA Corp. (NASDAQ: NVDA), following news that privately held Groq entered into a non-exclusive licensing agreement for AI inferenc...

blog post title

UBS Reaffirms Neutral View on Nike Despite Improving Brand Indicators

UBS reiterated a Neutral rating and a $62 price target on Nike Inc. (NYSE: NKE), citing improving brand momentum but a l...

blog post title

Freedom Capital Initiates MDU Resources Coverage With Hold Rating

Freedom Capital Markets initiated coverage on MDU Resources Group Inc. (NYSE: MDU) with a Hold rating and a $20 price ta...

blog post title

H.C. Wainwright Maintains Neutral Stance on Biohaven After BHV-7000 Setback

H.C. Wainwright reiterated a Neutral rating and $11 price target on Biohaven Pharmaceutical Holding Co. (NYSE: BHVN) fol...

blog post title

Agios Pharma Shares Surge After FDA Approval of Mitapivat

Agios Pharmaceuticals Inc. (NASDAQ: AGIO) shares jumped 18% on Thursday after the company received U.S. Food and Drug Ad...

blog post title

BMO Reiterates Market Perform on Halliburton, Sees Resilient North America Trends

BMO Capital reiterated a Market Perform rating and a $31 price target on Halliburton (NYSE: HAL), pointing to relative r...

blog post title

Raymond James Downgrades KB Home Amid Strategic and Competitive Concerns

Raymond James downgraded KB Home (NYSE: KBH) to Market Perform from Outperform, citing disappointment with fourth-quarte...

blog post title

Lake Street Raises Dave Inc Price Target as Credit Trends and Monetization Improve

Lake Street Capital Markets raised its price target on Dave Inc. (NASDAQ: DAVE) to $308 from $263 while reiterating a Bu...

blog post title

B. Riley Cuts WhiteFiber Target While Highlighting Execution Progress at NC-1

B. Riley lowered its price target on WhiteFiber Inc. (NASDAQ: WYFI) to $40 from $44 while maintaining a Buy rating, foll...

blog post title

Noble Capital Downgrades Comstock Mining as Capital Needs Remain Elevated

Noble Capital downgraded Comstock Mining Inc. (NYSE: LODE) to Market Perform from Outperform, citing ongoing near-term f...

blog post title

Americold Realty Trust Partners with On the Run to Enter Convenience Store Distribution

Americold Realty Trust, listed on the NYSE under the symbol COLD, is a leader in temperature-controlled logistics. The c...

blog post title

Recent Market Movers: A Detailed Analysis

In recent market analysis, several companies have experienced significant price movements, reflecting a range of underly...

blog post title

Hamilton Insurance Group, Ltd. (NYSE: HG) Price Target and Analyst Ratings Update

Hamilton Insurance Group, Ltd. (NYSE: HG) is a prominent player in the insurance industry, offering a range of insurance...

blog post title

Marvell Technology Inc. (NASDAQ:MRVL) Overview: Strategic Moves in the AI Semiconductor Industry

Marvell Technology Inc. (NASDAQ:MRVL) is a prominent player in the AI semiconductor industry, known for its innovative s...

blog post title

Meta's Price Target Trimmed at Baird, Flags Near-Term Sentiment Risks

Baird trimmed its price target on Meta Platforms Inc. (NASDAQ: META) to $815 from $820 while maintaining an Outperform r...

blog post title

Live Nation Price Target Raised as Evercore Sees Accelerating Earnings Power

Evercore ISI raised its price target on Live Nation Entertainment (NYSE: LYV) to $188 from $168 while maintaining an Out...

blog post title

Cytokinetics Price Target Lifted at Truist Following MYQORZO Approval

Truist Securities raised its price target on Cytokinetics, Inc. (NASDAQ: CYTK) to $84 from $70 while maintaining a Buy r...

blog post title

Evolution Petroleum Coverage Launched With Buy Rating at Freedom Capital

Freedom Capital Markets initiated coverage on Evolution Petroleum Corporation (NYSE: EPM) with a Buy rating and a price ...

blog post title

Rollins Price Target Increased as RBC Sees Consistent Growth Profile

RBC Capital Markets raised its price target on Rollins, Inc. (NYSE: ROL) to $70 from $62 while maintaining an Outperform...

blog post title

Jones Trading Initiates Coverage on MindMed, Highlights Psychedelic Opportunity

Jones Trading initiated coverage on MindMed (NASDAQ: MNMD) with a Buy rating and a $61 price target, pointing to the com...